Dr. Gregory Evans -- Pharmaceutical Payment Report

This page provides a comprehensive transparency report for Dr. Gregory Evans, a Internal Medicine physician based in City, SC. All payment data is sourced from the CMS Open Payments (Sunshine Act) database. Dr. Gregory Evans has received $14,761.95 in total pharmaceutical industry payments across 1 transactions from 1 pharmaceutical companies.

Physician Profile

The following profile information is sourced from the National Provider Identifier (NPI) registry and CMS Open Payments records.

  • Full Name: Dr. Gregory Evans
  • Medical Specialty: Internal Medicine
  • Practice Location: City, SC, South Carolina
  • NPI Number: 1939978862
  • Transparency Score: 50/100
  • Payment Records Span: 2025-09-14 to 2025-09-14

Payment Summary

Dr. Gregory Evans has received a total of $14,761.95 in pharmaceutical industry payments across 1 recorded transactions in the CMS Open Payments database. The average payment amount is $14,761.95 per transaction.

  • Total Payments Received: $14,761.95
  • Number of Transactions: 1
  • Average Payment: $14,761.95
  • Transparency Score: 50/100 -- This score reflects the overall payment profile relative to peers in Internal Medicine. A higher score indicates fewer or more routine payments.
  • Number of Pharma Relationships: 1 pharmaceutical companies

Payment Breakdown by Category

The following table shows how Dr. Gregory Evans's pharmaceutical payments break down by payment category. Understanding the mix of payment types provides important context about the nature of the doctor-pharma relationship.

Payment CategoryAmountDescription
Speaking & Education$14,761.95Promotional speaking, CME events, and educational presentations

The largest payment category for Dr. Gregory Evans is Speaking & Education, accounting for 100% ($14,761.95) of total pharmaceutical payments received. This suggests active involvement in pharmaceutical company advisory and educational programs.

Pharmaceutical Company Relationships

The following pharmaceutical and medical device companies have made payments to Dr. Gregory Evans. Click on any company name to view their full physician payment profile and spending patterns.

CompanyTotal PaidTransactions
Teva Pharmaceuticals$14,761.951

Dr. Gregory Evans has a financial relationship with Teva Pharmaceuticals, receiving $14,761.95 in total. Having a single pharmaceutical company relationship means all payments come from one source, which may indicate a focused consulting or research relationship.

AI Transparency Analysis

The following analysis was generated by artificial intelligence based on Dr. Gregory Evans's payment history, specialty peer comparisons, and payment pattern analysis. This analysis is not medical or legal advice.

Gregory Evans has received $14.8K across 1 pharmaceutical payments as a Internal Medicine physician in City, SC. Top paying companies include Teva Pharmaceuticals ($14.8K). Dr. Gregory Evans received a single large payment of $14,762 from Teva Pharmaceuticals in 2025, which represents 100% of his total pharmaceutical payments. The payment was of the type 'speaking', indicating it was likely for a speaking engagement or similar activity.

Patient Guidance: Questions to Ask Your Doctor

If Dr. Gregory Evans is your physician, here is practical guidance on how to understand and discuss pharmaceutical industry relationships:

Consumers should be aware that Dr. Gregory Evans has received significant payments from a single pharmaceutical company, which may influence his prescribing practices. Always feel free to ask your doctor directly about their pharmaceutical relationships.

Peer Comparison: How Dr. Gregory Evans Compares to Other Internal Medicine Physicians

Compared to peers in Internal Medicine, Dr. Gregory Evans has a relatively high concentration of payments from a single company, which is less common.

Recent Payment Records

The following table shows the most recent pharmaceutical industry payments recorded for Dr. Gregory Evans in the CMS Open Payments database. Click on any payment to view the full report.

CompanyAmountTypeDrug/DeviceDateConflict Level
Teva Pharmaceuticals$14,761.95speakingN/A2025-09-14Not Assessed

Frequently Asked Questions About Dr. Gregory Evans's Pharma Payments

Below are common questions patients ask about physician pharmaceutical payment data.

How much pharma money has Gregory Evans received?

Gregory Evans has received a total of $14.8K across 1 payments from pharmaceutical companies. This data is publicly reported under the CMS Open Payments (Sunshine Act) program.

Is Gregory Evans taking too much pharma money?

Gregory Evans has received $14.8K in pharmaceutical payments. Whether this is "too much" depends on the physician's specialty (Internal Medicine), the types of payments, and how they compare to peers. The largest payment category is speaking ($14.8K). Payment does not imply wrongdoing, but patients should be aware and can ask their doctor directly.

What pharma companies pay Gregory Evans?

The top pharmaceutical companies paying Gregory Evans are: Teva Pharmaceuticals ($14.8K). These payments cover various categories including consulting, meals, speaking fees, and research grants.

What kinds of payments does Gregory Evans receive?

Gregory Evans's payments by type: speaking: $14.8K.

Should I switch doctors because of pharma payments?

Pharma payments alone are not typically reason to switch doctors. Many payments are routine (like meals at educational events) and do not indicate compromised care. Focus on: (1) whether your doctor explains treatment options clearly, (2) whether generic alternatives are discussed, (3) the overall pattern of payments, not individual transactions. If you have concerns, ask your doctor directly.

How do Gregory Evans's payments compare to other Internal Medicine doctors?

To compare, look at the total amount ($14.8K), number of payments (1), and the types of payments received. Internal Medicine physicians may receive different payment amounts depending on subspecialty, geographic location, and academic affiliation. Use CMS Open Payments data to compare across the specialty.

How can I verify Gregory Evans's payment data?

You can verify this data directly through the CMS Open Payments database at openpaymentsdata.cms.gov. Search by physician name or NPI number (1939978862). All data is reported by pharmaceutical companies and verified by CMS. DoctorPharmaData aggregates this public data for easier access.

Do pharma payments affect prescribing quality?

Research published in JAMA Internal Medicine and other peer-reviewed journals shows a statistical association between pharmaceutical payments and prescribing patterns. However, correlation does not equal causation. Many physician-industry interactions are legitimate (research, education, advisory boards). The Sunshine Act was created to promote transparency so patients can make informed decisions.

What stands out about Gregory Evans's pharma payment profile?

Single large payment from a single company, indicating high concentration in pharmaceutical payments. Gregory Evans has received $14.8K in total pharma payments.

How does Gregory Evans compare to peers in Internal Medicine?

Compared to peers in Internal Medicine, Dr. Gregory Evans has a relatively high concentration of payments from a single company, which is less common.

Are Gregory Evans's pharma relationships typical for Internal Medicine?

Payment type suggests involvement in educational or promotional activities.

What should patients of Gregory Evans know about these payments?

Consumers should be aware that Dr. Gregory Evans has received significant payments from a single pharmaceutical company, which may influence his prescribing practices.

What patterns are visible in Gregory Evans's payment history?

No trend data available for previous years, limiting insight into payment history over time.

Understanding This Doctor Payment Report

This transparency report for Dr. Gregory Evans is based on data from the CMS Open Payments database, which is maintained by the Centers for Medicare and Medicaid Services under the Physician Payments Sunshine Act. Here are important things to understand:

  • Payment does not imply wrongdoing. Many pharmaceutical payments represent legitimate professional activities such as consulting on drug development, speaking at medical education events, and conducting clinical research.
  • Context matters. A large payment for conducting a clinical trial has very different implications than a large payment for promotional speaking. The payment breakdown by category above provides this context.
  • Peer comparison is important. Whether a payment amount is unusual depends heavily on the physician's specialty, geographic location, and career stage. Internal Medicine physicians may have very different payment norms than physicians in other fields.
  • Data may be incomplete. The CMS Open Payments database captures payments from pharmaceutical and medical device manufacturers. It does not include payments from other sources, such as hospitals, insurance companies, or government agencies.
  • Reporting thresholds apply. Small payments below certain thresholds may not be individually reported. The totals reflect payments above reporting minimums set by CMS regulations.

About the Physician Payments Sunshine Act

The Physician Payments Sunshine Act, enacted as Section 6002 of the Affordable Care Act in 2010, requires pharmaceutical and medical device companies to report payments and other transfers of value to physicians and teaching hospitals to CMS. This law was designed to increase transparency in the financial relationships between the healthcare industry and medical providers.

Under this law, Dr. Gregory Evans's pharmaceutical payments are publicly disclosed. The types of reportable transactions include consulting fees, compensated speaking or educational activities, honoraria, gifts, entertainment, food and beverages, travel and lodging, education or conference attendance, research grants, charitable contributions, royalties or licenses, current or prospective ownership interests, and direct compensation for services other than consulting.

The Open Payments data for Dr. Gregory Evans and all other physicians can be accessed at the official CMS Open Payments website.

Other Internal Medicine Physicians

Compare Dr. Gregory Evans's pharmaceutical payments with other Internal Medicine physicians ranked by total pharma payments received.

PhysicianStateTotal Payments
Karen HarrisAL$373,560.30
Andrew YoungMN$373,004.12
Catherine MorrisMI$329,087.36
Benjamin CookAL$290,577.64
Patricia DavisIN$229,890.74
Karen HarrisPA$223,458.75
Charles BakerOH$174,454.86
Amanda LewisTN$161,516.05
Amanda LewisAL$145,697.34
Christine EdwardsTX$144,283.94

Top Doctors in South Carolina

These physicians in South Carolina have received the highest pharmaceutical payments. See how Dr. Gregory Evans compares to peers in the same state.

PhysicianSpecialtyTotal Payments
Susan TaylorRheumatology$307,858.47
Paul TurnerRare Disease$206,441.37
Steven GreenHematology$190,406.64
Lisa GarciaNephrology$175,343.66
Emily ThompsonPsychiatry$152,112.87
Michael RodriguezOncology$118,303.96
Jeffrey CampbellNeurology$117,110.39
Heather MitchellDermatology$111,176.99
Paul TurnerOncology$101,141.20
Karen HarrisOphthalmology$88,120.79

Related Resources

Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice. Consult your healthcare provider about any concerns.